Cargando…

Transcription factors zeb1, twist and snai1 in breast carcinoma

BACKGROUND: Epitheliomesenchymal transition (EMT) is the process where cancer cells attain fibroblastic features and are thus able to invade neighboring tissues. Transcriptional factors zeb1, snai1 and twist regulate EMT. METHODS: We used immunohistochemistry to investigate the expression of zeb1, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Soini, Ylermi, Tuhkanen, Hanna, Sironen, Reijo, Virtanen, Ismo, Kataja, Vesa, Auvinen, Päivi, Mannermaa, Arto, Kosma, Veli-Matti
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055233/
https://www.ncbi.nlm.nih.gov/pubmed/21324165
http://dx.doi.org/10.1186/1471-2407-11-73
_version_ 1782200126348984320
author Soini, Ylermi
Tuhkanen, Hanna
Sironen, Reijo
Virtanen, Ismo
Kataja, Vesa
Auvinen, Päivi
Mannermaa, Arto
Kosma, Veli-Matti
author_facet Soini, Ylermi
Tuhkanen, Hanna
Sironen, Reijo
Virtanen, Ismo
Kataja, Vesa
Auvinen, Päivi
Mannermaa, Arto
Kosma, Veli-Matti
author_sort Soini, Ylermi
collection PubMed
description BACKGROUND: Epitheliomesenchymal transition (EMT) is the process where cancer cells attain fibroblastic features and are thus able to invade neighboring tissues. Transcriptional factors zeb1, snai1 and twist regulate EMT. METHODS: We used immunohistochemistry to investigate the expression of zeb1, twist and snai1 in tumor and stromal compartments by in a large set of breast carcinomas. The results were compared with estrogen and progesterone receptor status, HER2 amplification, grade, histology, TNM status and survival of the patients. RESULTS: Nuclear expression for twist was seen in the epithelial tumor cell compartment in 3.6% and for snai1 in 3.1% of the cases while zeb1 was not detected at all in these areas. In contrast, the tumor stromal compartment showed nuclear zeb1 and twist expression in 75% and 52.4% of the cases, respectively. Although rare, nuclear expression of twist in the epithelial tumor cell compartment was associated with a poor outcome of the patients (p = 0.054 log rank, p = 0.013, Breslow, p = 0.025 Tarone-Ware). Expression of snai1, or expression of zeb1 or twist in the stromal compartment did not have any prognostic significance. Furthermore, none of these factors associated with the size of the tumors, nor with the presence of axillary or distant metastases. Expression of zeb1 and twist in the stromal compartment was positively associated with a positive estrogen or progesterone receptor status of the tumors. Stromal zeb1 expression was significantly lower in ductal in situ carcinomas than in invasive carcinomas (p = 0.020). Medullary carcinomas (p = 0.017) and mucinous carcinomas (p = 0.009) had a lower stromal expression of zeb1 than ductal carcinomas. Stromal twist expression was also lower in mucinous (p = 0.017) than in ductal carcinomas. CONCLUSIONS: Expression of transcriptional factors zeb1 and twist mainly occur in the stromal compartment of breast carcinomas, possibly representing two populations of cells; EMT transformed neoplastic cells and stromal fibroblastic cells undergoing activation of zeb1 and twist due to growth factors produced by the tumor. However, epithelial expression of twist was associated with a poor prognosis, hinting at its importance in the spread of breast carcinoma.
format Text
id pubmed-3055233
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30552332011-03-12 Transcription factors zeb1, twist and snai1 in breast carcinoma Soini, Ylermi Tuhkanen, Hanna Sironen, Reijo Virtanen, Ismo Kataja, Vesa Auvinen, Päivi Mannermaa, Arto Kosma, Veli-Matti BMC Cancer Research Article BACKGROUND: Epitheliomesenchymal transition (EMT) is the process where cancer cells attain fibroblastic features and are thus able to invade neighboring tissues. Transcriptional factors zeb1, snai1 and twist regulate EMT. METHODS: We used immunohistochemistry to investigate the expression of zeb1, twist and snai1 in tumor and stromal compartments by in a large set of breast carcinomas. The results were compared with estrogen and progesterone receptor status, HER2 amplification, grade, histology, TNM status and survival of the patients. RESULTS: Nuclear expression for twist was seen in the epithelial tumor cell compartment in 3.6% and for snai1 in 3.1% of the cases while zeb1 was not detected at all in these areas. In contrast, the tumor stromal compartment showed nuclear zeb1 and twist expression in 75% and 52.4% of the cases, respectively. Although rare, nuclear expression of twist in the epithelial tumor cell compartment was associated with a poor outcome of the patients (p = 0.054 log rank, p = 0.013, Breslow, p = 0.025 Tarone-Ware). Expression of snai1, or expression of zeb1 or twist in the stromal compartment did not have any prognostic significance. Furthermore, none of these factors associated with the size of the tumors, nor with the presence of axillary or distant metastases. Expression of zeb1 and twist in the stromal compartment was positively associated with a positive estrogen or progesterone receptor status of the tumors. Stromal zeb1 expression was significantly lower in ductal in situ carcinomas than in invasive carcinomas (p = 0.020). Medullary carcinomas (p = 0.017) and mucinous carcinomas (p = 0.009) had a lower stromal expression of zeb1 than ductal carcinomas. Stromal twist expression was also lower in mucinous (p = 0.017) than in ductal carcinomas. CONCLUSIONS: Expression of transcriptional factors zeb1 and twist mainly occur in the stromal compartment of breast carcinomas, possibly representing two populations of cells; EMT transformed neoplastic cells and stromal fibroblastic cells undergoing activation of zeb1 and twist due to growth factors produced by the tumor. However, epithelial expression of twist was associated with a poor prognosis, hinting at its importance in the spread of breast carcinoma. BioMed Central 2011-02-16 /pmc/articles/PMC3055233/ /pubmed/21324165 http://dx.doi.org/10.1186/1471-2407-11-73 Text en Copyright ©2011 Soini et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Soini, Ylermi
Tuhkanen, Hanna
Sironen, Reijo
Virtanen, Ismo
Kataja, Vesa
Auvinen, Päivi
Mannermaa, Arto
Kosma, Veli-Matti
Transcription factors zeb1, twist and snai1 in breast carcinoma
title Transcription factors zeb1, twist and snai1 in breast carcinoma
title_full Transcription factors zeb1, twist and snai1 in breast carcinoma
title_fullStr Transcription factors zeb1, twist and snai1 in breast carcinoma
title_full_unstemmed Transcription factors zeb1, twist and snai1 in breast carcinoma
title_short Transcription factors zeb1, twist and snai1 in breast carcinoma
title_sort transcription factors zeb1, twist and snai1 in breast carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055233/
https://www.ncbi.nlm.nih.gov/pubmed/21324165
http://dx.doi.org/10.1186/1471-2407-11-73
work_keys_str_mv AT soiniylermi transcriptionfactorszeb1twistandsnai1inbreastcarcinoma
AT tuhkanenhanna transcriptionfactorszeb1twistandsnai1inbreastcarcinoma
AT sironenreijo transcriptionfactorszeb1twistandsnai1inbreastcarcinoma
AT virtanenismo transcriptionfactorszeb1twistandsnai1inbreastcarcinoma
AT katajavesa transcriptionfactorszeb1twistandsnai1inbreastcarcinoma
AT auvinenpaivi transcriptionfactorszeb1twistandsnai1inbreastcarcinoma
AT mannermaaarto transcriptionfactorszeb1twistandsnai1inbreastcarcinoma
AT kosmavelimatti transcriptionfactorszeb1twistandsnai1inbreastcarcinoma